Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells

• Breanna DiAndreth,
• Kiran Deshmukh,
• Jee-Young Mock,
• Talar Tokatlian,
• Alexander Kamb,
• Shruti Sharma,
• Grace E Asuelime,
• Dora Toledo Warshaviak,
• Mark E Daris,
• Kristian Bolanos,
• Breanna L Luna,
• Martin S Naradikian,
• Agnes E Hamburger

Affiliations

Breanna DiAndreth

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Kiran Deshmukh

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Jee-Young Mock

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Talar Tokatlian

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Alexander Kamb

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Shruti Sharma

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Grace E Asuelime

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Dora Toledo Warshaviak

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Mark E Daris

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Kristian Bolanos

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Breanna L Luna

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Martin S Naradikian

A2 Biotherapeutics Inc, Agoura Hills, California, USA

Agnes E Hamburger

A2 Biotherapeutics Inc, Agoura Hills, California, USA